Heron Therapeutics, Inc. /De/ (HRTX) insider trading.
In Q3 2026, insiders at Heron Therapeutics, Inc. /De/ reported 18 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 18
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 4
- Last filed
- 2026-08-10
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Duarte Ira | Officer · EVP, Chief Financial Officer | 6 | 0 | 0 |
| Forbes William P | Officer · EVP, Chief Development Officer | 6 | 0 | 0 |
| Hensley Mark Earl | Officer · Chief Operating Officer | 3 | 0 | 0 |
| Collard Craig A | Director, Officer · Chief Executive Officer | 3 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-06 | Hensley Mark Earl | M (A) | 31,250 | — | 179,789 | Form 4 |
| 2026-08-06 | Hensley Mark Earl | F (D) | 8,888 | $0.5 | 170,901 | Form 4 |
| 2026-07-31 | Collard Craig A | M (A) | 34,789 | — | 856,492 | Form 4 |
| 2026-07-31 | Duarte Ira | M (A) | 11,694 | — | 285,225 | Form 4 |
| 2026-07-31 | Duarte Ira | F (D) | 3,326 | $0.5 | 281,899 | Form 4 |
| 2026-07-31 | Forbes William P | M (A) | 11,694 | — | 244,499 | Form 4 |
| 2026-07-31 | Forbes William P | F (D) | 3,326 | $0.5 | 241,173 | Form 4 |
| 2026-07-31 | Hensley Mark Earl | M (A) | 11,769 | — | 148,539 | Form 4 |
| 2026-07-30 | Collard Craig A | M (A) | 50,021 | — | 821,703 | Form 4 |
| 2026-07-30 | Duarte Ira | F (D) | 3,850 | $0.5 | 273,531 | Form 4 |
| 2026-07-30 | Duarte Ira | M (A) | 13,535 | — | 277,381 | Form 4 |
| 2026-07-30 | Forbes William P | F (D) | 3,348 | $0.5 | 232,805 | Form 4 |
| 2026-07-30 | Forbes William P | M (A) | 11,769 | — | 236,153 | Form 4 |
| 2026-07-19 | Duarte Ira | M (A) | 3,874 | — | 264,947 | Form 4 |
| 2026-07-19 | Duarte Ira | F (D) | 1,101 | $0.47 | 263,846 | Form 4 |
| 2026-07-19 | Forbes William P | F (D) | 1,101 | $0.47 | 224,384 | Form 4 |
| 2026-07-19 | Forbes William P | M (A) | 3,874 | — | 225,485 | Form 4 |
| 2026-07-19 | Collard Craig A | M (A) | 13,797 | — | 771,682 | Form 4 |
Transaction codes in this quarter
Get HRTX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=818033&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · HRTX company page · Heron Therapeutics, Inc. /De/ on SEC.gov
Questions
Are insiders buying or selling Heron Therapeutics, Inc. /De/ (HRTX)?
In Q3 2026, insiders at Heron Therapeutics, Inc. /De/ reported 18 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Heron Therapeutics, Inc. /De/ insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/hrtx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.